Page last updated: 2024-08-25

cyclopentenyl cytosine and Benign Neoplasms

cyclopentenyl cytosine has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Leen, R; Van Gennip, AH; Van Kuilenburg, AB; Verschuur, AC	1
Allegra, CJ; Bastian, A; Chen, AP; Dahut, W; Ford, H; Hamilton, JM; Kelley, JA; Politi, PM; Setser, A; Xie, F	1

Trials

1 trial(s) available for cyclopentenyl cytosine and Benign Neoplasms

Article	Year
Phase I clinical trial of continuous infusion cyclopentenyl cytosine. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Carbon-Nitrogen Ligases; Chromatography, High Pressure Liquid; Cytidine; Female; Humans; Hypotension; Infusions, Intravenous; Ligases; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms	1995

Other Studies

1 other study(ies) available for cyclopentenyl cytosine and Benign Neoplasms

Article	Year
Increased cytotoxicity of 2',2'-difluoro-2'-deoxycytidine in human leukemic cell-lines after a preincubation with cyclopentenyl cytosine. Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Carbon-Nitrogen Ligases; Cell Line, Tumor; Cell Separation; Clinical Trials as Topic; Cytidine; Deoxycytidine; DNA; Dose-Response Relationship, Drug; Flow Cytometry; Gemcitabine; HL-60 Cells; Humans; Necrosis; Neoplasms; Time Factors	2004

Article

Year

Increased cytotoxicity of 2',2'-difluoro-2'-deoxycytidine in human leukemic cell-lines after a preincubation with cyclopentenyl cytosine.

Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Carbon-Nitrogen Ligases; Cell Line, Tumor; Cell Separation; Clinical Trials as Topic; Cytidine; Deoxycytidine; DNA; Dose-Response Relationship, Drug; Flow Cytometry; Gemcitabine; HL-60 Cells; Humans; Necrosis; Neoplasms; Time Factors

2004